CUAMC
AVDL

China Universal Asset Management Company’s Avadel Pharmaceuticals AVDL Stock Holding History

China Universal Asset Management Company’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,020
Closed -$260K – 505
2025
Q3 		$260K Sell
17,020
-2,410
-12% -$31.4K 0.02% 310
2025
Q2 		$172K Buy
19,430
+102
+0.5% +$896 0.02% 324
2025
Q1 		$151K Sell
19,328
-1,104
-5% -$9.24K 0.01% 333
2024
Q4 		$215K Buy
20,432
+1,916
+10% +$23.3K 0.02% 320
2024
Q3 		$243K Buy
18,516
+7,224
+64% +$110K 0.03% 281
2024
Q2 		$159K Buy
+11,292
New +$184K 0.02% 267
2024
Q1 		– Sell
-10,327
Closed -$146K – 442
2023
Q4 		$146K Buy
10,327
+8,029
+349% +$94.3K 0.03% 243
2023
Q3 		$23.7K Buy
2,298
+1,454
+172% +$19.5K 0.01% 289
2023
Q2 		$13.9K Sell
844
-7
-0.8% -$91 ﹤0.01% 300
2023
Q1 		$7.79K Buy
851
+233
+38% +$1.92K ﹤0.01% 324
2022
Q4 		$4.42K Buy
618
+66
+12% +$463 ﹤0.01% 311
2022
Q3 		$3K Buy
+552
New +$3.04K ﹤0.01% 320

Other funds holding AVDL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

China Universal Asset Management Company's AVDL Position: Q4 2025 in Review

China Universal Asset Management Company sold out of Avadel Pharmaceuticals (AVDL) in Q4 2025, closing a stake of 17,020 shares — an estimated $260K sold.

China Universal Asset Management Company first reported a position in AVDL in Q3 2022 and held it in 12 quarters. The position peaked at $260K in Q3 2025. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

  • China Universal Asset Management Company reported no remaining Avadel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 17,020 Avadel Pharmaceuticals shares in Q4 2025, an estimated $260K.
  • China Universal Asset Management Company first reported a position in Avadel Pharmaceuticals in Q3 2022 and held it in 12 quarters.
  • China Universal Asset Management Company's Avadel Pharmaceuticals position peaked at $260K in Q3 2025.
  • 207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on China Universal Asset Management Company's 13F filing for Q4 2025, filed 29 Jan 2026.